Capital Allergy Respiratory Disease Center is a clinical research site located in Sacramento, California, United States 95819.
Crixeo Clinical Trials Trust Score: 14/100 (FAILING). This profile has not yet been claimed by the site owner.
Capital Allergy Respiratory Disease Center has participated in 5 clinical trials.
Therapeutic areas: Cystic Fibrosis, Primary Immunodeficiency Diseases (PID), COPD.
Sponsors: Merck Sharp & Dohme LLC, Baxalta now part of Shire, Sunovion Respiratory Development Inc..
Is this your site? Claim your profile and control the information sponsors and patients see.
Browse all research sites in California · View every site in Sacramento
Trust Score: 14/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.
Capital Allergy Respiratory Disease Center has a Crixeo Trust Score of 14/100 (FAILING). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.
Capital Allergy Respiratory Disease Center has 5 clinical trials on record. Their work covers Cystic Fibrosis, Primary Immunodeficiency Diseases (PID), COPD.
Capital Allergy Respiratory Disease Center has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.
Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.